SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ploni who wrote (3018)3/25/1998 4:44:00 PM
From: Richard Ogier  Read Replies (1) of 7041
 
Here is a summary of the patent from uspto.gov
Lowrey is the inventor.

United States Patent
5,731,339
Lowrey
Mar. 24, 1998

Methods and formulations for modulating the human sexual response
Inventors:
Lowrey; Fred (Lincoln, NE).
Assignee:
Zonagen, Inc. (The Woodlands, TX).
Appl. No.:
431,145
Filed:
Apr. 28, 1995

Intl. Cl. :
A61K 31/415
Current U.S. Cl.:
514/400
Field of Search:
514/400


Primary Examiner: Spivack; Phyllis G.
Attorney, Agent or Firm: Marshall, O'Toole, Gerstein, Murray & Borun

Abstract

Improved methods for modulating the human sexual response by orally administering a rapidly dissolving tablet comprising phentolamine
mesylate or phentolamine hydrochloride is disclosed.

37 Claims, No Drawings
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext